James Kinderknecht, M.D. is a sports medicine internal medicine in New York, NY with 38 years of experience. The provider is an internist trained to be responsible for continuous care in the field of sports medicine, not only for the enhancement of health and fitness, but also for the prevention of injury and illness. A sports medicine physician must have knowledge and experience in the promotion of wellness and the prevention of injury. Knowledge about special areas of medicine such as exercise physiology, biomechanics, nutrition, psychology, physical rehabilitation, epidemiology, physical evaluation, injuries (treatment and prevention and referral practice) and the role of exercise in promoting a healthy lifestyle are essential to the practice of sports medicine. The sports medicine physician requires special education to provide the knowledge to improve the healthcare of the individual. James Kinderknecht, M.D. NPI is 1740273325. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
Education
Medical School: UNIVERSITY OF KANSAS SCHOOL OF MED (KC/WICH/SAL)
Graduation Year:1986
The provider's business location address is:
535 E 70TH ST
NEW YORK, NY
ZIP 10021-823
Phone: (646) 797-8526
Fax: (646) 797-8267
The NPI 1740273325 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
- Aspiration and/or injection of large joint or joint capsule (HCPCS:20610)
The enumeration date for this NPI number is 8/29/2005 and was last updated on 2/1/2021.